A comprehensive view of World Vaccine Congress. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Novavax to present data on updated COVID-19 vaccine and influenza and COVID-19-Influenza combination vaccines at World Vaccine Congress 2024; company to discuss IgG subclass responses and Fcγ-mediated effector functions following different vaccinations
Published:
April 01, 2024
by Novavax Inc.
|
Novavax to advance science supporting protein-based vaccine technology at IDWeek 2023 and World Vaccine Congress Europe 2023; Novavax to present two posters sessions at IDWeek, three oral presentations at World Vaccine Congress Europe
Published:
October 11, 2023
by Novavax Inc.
|
Ask us about our Health Care Sector market view